BLS PHARMACEUTICALS LIMITED (formerly Bioxyne Limited) ACN 084 464 193 NOTICE OF ANNUAL GENERAL MEETING Explanatory Memorandum and Proxy Form Time: 4:00pm AEDT Date: 24 November 2026 To be held at Addisons, Level 10, 2 Park Street Sydney NSW 2000 This Notice of Annual General Meeting and...
BLS Pharmaceuticals: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 43 pages · English
Summary by 6ix AI
The meeting is scheduled to take place at a specified location in Sydney, and shareholders are encouraged to vote by proxy if they cannot attend in person. Key resolutions include the adoption of the remuneration report, re-election of directors, and approval of an equity incentive plan. The document also outlines voting procedures and restrictions for certain resolutions, ensuring compliance with corporate governance standards.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BLS Pharmaceuticals Limited on 6ix
Earlier from BLS Pharmaceuticals
- Q1 FY2027 Quarterly Activities Update
- BLS Quarterly Activities Report September 2026 Revised
- Quarterly Activities/Appendix 4C Cash Flow Report
- Ceasing to be a substantial holder
- Becoming a substantial holder
Later from BLS Pharmaceuticals
- Letter to Shareholders re Annual General Meeting
- Application for quotation of securities - BLS
- Directors Change of Interest Notice X 2
Follow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals